16:09 EST Cadrenal Therapeutics (CVKD) files to sell 590K shares of common stock for holders
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVKD:
- Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
- Cadrenal Therapeutics Advances Tecarfarin Development
- Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
- Cadrenal Therapeutics raises $5.1M via at-the-market facility
- Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue